NEC Bio Therapeutics Unveils Promising Results for AI-Powered Oral Cancer Vaccine
NEC Bio Therapeutics has announced promising interim results from its Phase 1 clinical trial of NECVAX-NEO1, an innovative AI-driven oral cancer vaccine, at the ESMO Immuno-Oncology Congress. This groundbreaking vaccine targets solid tumors and has shown a high disease control rate among participants, indicating its potential as a personalized treatment option for challenging cancers.
University of Birmingham researchers developing special lollipops for mouth cancer diagnosis
University of Birmingham researchers have received £350,000 to develop special lollipops for diagnosing mouth cancer. The innovative hydrogel-based lollipops aim to provide a less painful and more cost-effective alternative to the current tissue sample testing method. With the potential to revolutionize mouth cancer diagnosis, this project offers hope for a more patient-friendly and GP-accessible diagnostic device.